Stoke Therapeutics (STOK) Other Gross PP&E Adjustments (2018 - 2026)
Stoke Therapeutics' quarterly Other Gross PP&E Adjustments came in at -$5.7 million in Q1 2026, down 8.75% year-on-year from -$6.3 million in Q1 2025, and down 161.94% quarter-over-quarter from $9.2 million in Q4 2025.
Stoke Therapeutics has reported Other Gross PP&E Adjustments for 9 years, with the latest figure at -$5.7 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 8.75% year-over-year to -$5.7 million; the trailing twelve-month figure through Mar 2026 stood at -$5.7 million (down 8.75% YoY), and the FY2025 full-year result was $9.2 million, up 26.31% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$5.7 million, down from $9.2 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $9.2 million in Q4 2025, with the low at -$7.8 million in Q1 2024.
- Average Other Gross PP&E Adjustments over 5 years is -$2.7 million, with a median of -$5.3 million recorded in 2025.
- Peak annual rise in Other Gross PP&E Adjustments reached 101.8% in 2022, while the deepest fall reached 496.1% in 2022.
- Tracing STOK's Other Gross PP&E Adjustments over 5 years: stood at $5.6 million in 2022, then soared by 38.17% to $7.7 million in 2023, then fell by 5.67% to $7.3 million in 2024, then rose by 26.31% to $9.2 million in 2025, then tumbled by 161.94% to -$5.7 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$5.7 million (Q1 2026), $9.2 million (Q4 2025), and -$5.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - | -5.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.72 Mn |
| Mar 31, 2026 | -5.72 Mn |
| Dec 31, 2025 | 9.23 Mn |
| Dec 31, 2025 | 9.23 Mn |
| Sep 30, 2025 | -5.38 Mn |
| Sep 30, 2025 | -5.38 Mn |
| Jun 30, 2025 | -4.27 Mn |
| Jun 30, 2025 | -4.27 Mn |
| Mar 31, 2025 | -5.26 Mn |
| Mar 31, 2025 | -5.26 Mn |
| Dec 31, 2024 | 7.30 Mn |
| Dec 31, 2024 | 7.30 Mn |
| Sep 30, 2024 | -6.60 Mn |
| Sep 30, 2024 | -6.60 Mn |
| Jun 30, 2024 | -7.65 Mn |
| Jun 30, 2024 | -7.65 Mn |
| Mar 31, 2024 | -7.79 Mn |
| Mar 31, 2024 | -7.79 Mn |
| Dec 31, 2023 | 7.74 Mn |
| Dec 31, 2023 | 7.74 Mn |
| Sep 30, 2023 | -3.61 Mn |
| Sep 30, 2023 | -3.61 Mn |
| Jun 30, 2023 | -4.44 Mn |
| Jun 30, 2023 | -4.44 Mn |
| Mar 31, 2023 | -5.18 Mn |
| Mar 31, 2023 | -5.18 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Sep 30, 2022 | -5.92 Mn |
| Sep 30, 2022 | -5.92 Mn |
| Jun 30, 2022 | -7.18 Mn |
| Jun 30, 2022 | -7.18 Mn |
| Mar 31, 2022 | -6.01 Mn |
| Mar 31, 2022 | -6.01 Mn |
| Dec 31, 2021 | 2.78 Mn |
| Dec 31, 2021 | 2.78 Mn |
| Sep 30, 2021 | -4.02 Mn |
| Sep 30, 2021 | -4.02 Mn |
| Jun 30, 2021 | -1.21 Mn |
| Jun 30, 2021 | -1.21 Mn |
| Mar 31, 2021 | -1.54 Mn |
| Mar 31, 2021 | -1.54 Mn |
| Dec 31, 2020 | 2.66 Mn |
| Dec 31, 2020 | 2.66 Mn |
| Sep 30, 2020 | -1.94 Mn |
| Sep 30, 2020 | -1.94 Mn |
| Jun 30, 2020 | -1.94 Mn |
| Jun 30, 2020 | -1.94 Mn |
| Mar 31, 2020 | -2.10 Mn |
| Mar 31, 2020 | -2.10 Mn |
| Dec 31, 2019 | 3.10 Mn |
| Dec 31, 2019 | 3.10 Mn |
| Sep 30, 2019 | -339,000.00 |
| Sep 30, 2019 | -339,000.00 |
| Jun 30, 2019 | -988,000.00 |
| Jun 30, 2019 | -988,000.00 |
| Dec 31, 2018 | 1.37 Mn |
| Dec 31, 2018 | 1.37 Mn |